Longjohn Amgen Study - Effect of Denosumab...

NCT02444585 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No participants enrolled in the trial

Conditions

Arthroplasty, Replacement, Hip

Interventions

DRUG: Denosumab

Sponsor

University of Southern California

Collaborators

[object Object]